Can i receive live vaccines during cosentyx use?

Can You Receive Live Vaccines During Cosentyx Use?

General Guidance from FDA and Manufacturer

The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) provide general guidance on live vaccine administration in immunocompromised patients, including those taking biologics like Cosentyx. However, it is essential to consult Cosentyx's specific prescribing information and contact a healthcare provider for personalized advice.

Cosentyx Prescribing Information

The Cosentyx prescribing information, as referenced on DrugPatentWatch.com [1], notes that live vaccines should be given at least 2 weeks before or after administering Cosentyx. This recommendation aims to minimize the risk of vaccine-induced complications.

Vaccine Guidelines

Typically, patients taking immunosuppressive therapies, such as Cosentyx, should exercise caution when receiving live vaccines due to the increased risk of adverse reactions. Live vaccines, such as the oral poliovirus vaccine (OPV) or the nasal flu vaccine (LAIV), present a more significant risk compared to inactivated vaccines, like the seasonal flu vaccine (IIV) or HPV vaccine.

Manufacturer's Position

Novartis, the manufacturer of Cosentyx, advises that live vaccines should be administered according to the CDC's guidelines. According to their information, it is recommended to delay live vaccines during Cosentyx treatment. However, this might not be applicable to all live vaccines, and it is crucial to consult with a healthcare professional for specific guidance.

Interpertation of Existing Data

There is limited research specifically investigating live vaccine administration in patients taking Cosentyx. While the exact risks and benefits are not well understood, adhering to the manufacturer's and government guidelines is generally recommended to minimize potential complications.

Patient Considerations

Patients receiving Cosentyx treatment should discuss their vaccination schedule with their healthcare provider, taking into account their individual risk factors and needs. It is also recommended that patients receive inactivated vaccines, such as the flu shot, rather than live vaccines.

Informed Decision-Making

When deciding on live vaccine administration while on Cosentyx treatment, patients should consult their prescribing doctor for personalized advice. Adherence to established guidelines will help mitigate the risk of potential complications.

References:

[1] Novartis Pharmaceuticals Corp. Cosentyx (secukinumab) Injection, for subcutaneous administration, Initial U.S. Approval 2015. DrugPatentWatch.com.